Fred Hutchinson Cancer Research Center epidemiologist Dr. Christopher Li was recently selected as the inaugural recipient of…
dcorriganFebruary 15, 2022
Virus experts at Fred Hutchinson Cancer Research Center and the University of Washington are starting…
dcorriganFebruary 14, 2022
Curevo Vaccine has secured $60 million in Series A financing. Curevo, a clinical-stage biotechnology company, is developing…
dcorriganFebruary 11, 2022
SEngine Precision Medicine, a precision oncology company revolutionizing cancer therapies by pre-testing drugs on patient-derived…
dcorriganFebruary 11, 2022
The authors suggest that brain endothelial cells can have different responses to injury depending on…
dcorriganFebruary 11, 2022
As internal organs go, the human liver has a rare superpower – the ability to…
dcorriganFebruary 10, 2022
When an experimental new cancer treatment shows promising results for many patients, these successes are…
dcorriganFebruary 10, 2022
Charting millions of unknown neurons in the octopus arm. Coaxing engineered mini-organs to grow their…
dcorriganFebruary 10, 2022
The authors used a technique called design-based stereology to precisely locate eosinophils in the airway…
dcorriganFebruary 9, 2022
